BioSpace News Archive

Business

Xenon Pharmaceuticals Inc. Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. (JOBS); Xenon Potentially Eligible for up to $185 Million

June 11, 2009
·
2 min read
Business

Metabasis Therapeutics, Inc. Announces Merck & Co., Inc. Has Selected a Lead AMPK Activator for Late Preclinical Development; Triggers $6 Million Payment to Metabasis

June 11, 2009
·
3 min read
Business

Neuromed Pharmaceuticals Announces that Merck & Co., Inc. (JOBS) Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels

June 11, 2009
·
2 min read
Drug Development

GTX Corp Presents Phase II Ostarine (MK-2866) Cancer Cachexia Clinical Trial Results at Endocrine Society Annual Meeting

June 11, 2009
·
1 min read
Drug Development

GTx, Inc. Muscle Drug Boosts Lean Body Mass in Mid-stage Trial

June 11, 2009
·
1 min read
Drug Development

Pfizer Inc.'s (JOBS) Oral JAK-3 Inhibitor Demonstrates Statistically Significant Response For Patients with Rheumatoid Arthritis, New Phase 2 Studies Show

June 11, 2009
·
6 min read
Policy

FDA Panel Backs AstraZeneca PLC (JOBS), Eli Lilly and Company (JOBS), Pfizer Inc. (JOBS) Antipsychotic Drugs for Kids

June 11, 2009
·
1 min read
Drug Development

Wyeth: New Phase 3 Data Continue to Indicate that Wyeth’s Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease

June 11, 2009
·
7 min read
Policy

Transcept Pharmaceuticals, Inc. Sees 3-Month Extension for Sleep Drug Review

June 11, 2009
·
4 min read
FDA

STAAR Surgical Company Receives FDA Clearance for the Epiphany(TM) Injector System

June 11, 2009
·
3 min read